Asia Pacific Radiofrequency Ablation Devices Market Analysis, Growth Trends, And Segment Forecasts, 2012 To 2020

Published: Oct, 2014 | Pages: 75 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

Overview

This study is a comprehensive report on the Radiofrequency Ablation Devices market, with particular focus on industry outlook, growth drivers, market segmentation, competitive scenario and critical success factors. This research report provides statistical data, including market size by product and application for historic years of 2012 and 2013, with forecast up to 2020.

The report firstly provides market segmentation, current market scenario, growth prospects and value chain analysis. Then the report analyzes the Asia Pacific Radiofrequency Ablation Devices market dynamics in-depth which include growth feasibility analysis, market driver impact analysis, five force analysis, and PESTEL analysis. The growth feasibility analysis points out key areas in this industry that represent high growth opportunities for market players over the forecast period.

Additionally, this report includes comprehensive industry landscape, with market dynamics, drivers, restraints, and opportunities. This report will help you discover the latest market trends and reveal sources of future market growth for Asia Pacific Radiofrequency Ablation Devices market. If you are looking for a detailed report on Radiofrequency Ablation Devices market, our research will save you time and effort while empowering you to make informed decisions.

This research report on Radiofrequency Ablation Devices market includes: Market estimate and forecast of Radiofrequency Ablation Devices market Key factors driving the growth of Radiofrequency Ablation Devices market Detailed profile of the key players operating in this market Five year forecasts of market trends and market growth Challenges and opportunities in Radiofrequency Ablation Devices market Why buy this report? Radiofrequency Ablation Devices market size, growth rate and forecast to 2020 Track key market trends, opportunities and threats Make informed decisions related to marketing, branding, strategy building, and market development Competitive landscape with company market share and detailed profiles of key market players

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Radiofrequency Ablation Devices Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Radiofrequency Ablation Devices Market dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Radiofrequency Ablation Devices PESTEL Analysis
2.6. Radiofrequency Ablation Devices Company Market Share Analysis, 2013

Chapter 3. Radiofrequency Ablation Devices Application Outlook
3.1. Surgical Oncology Volume and Revenue Estimates, 2012 - 2020
3.2. Cardiology & Cardiac Rhythm Management Volume and Revenue Estimates, 2012 - 2020
3.3. Pain Management Volume and Revenue Estimates, 2012 - 2020
3.4. Gynecology Volume and Revenue Estimates, 2012 - 2020
3.5. Hypertension Volume and Revenue Estimates, 2012 - 2020
3.6. Cosmetology Volume and Revenue Estimates, 2012 - 2020

Chapter 4. Radiofrequency Ablation Devices Product Outlook
4.1. Radiofrequency ablation devices market share, by product, 2013 & 2020
4.2. Capital Equipment
4.2.1. Market Estimates, By Application, 2012 2020, Revenue & Volume
4.3. Reusable Equipment
4.3.1. Market Estimates, By Application, 2012 2020, Revenue & Volume
4.3.1.1. Reusable Radiofrequency Probes
4.3.1.2. Reusable Radiofrequency Electrodes
4.4. Disposable Equipment
4.4.1. Market Estimates, By Application, 2012 2020, Revenue & Volume
4.4.1.1. Disposable Radiofrequency Cannulas
4.4.1.2. Disposable Radiofrequency Needles
4.4.1.3. Disposable Radiofrequency Single-Use probes
4.4.1.4. Disposable Radiofrequency Single-Use Electrodes

Chapter 5 Competitive Landscape
5.1 Accuray
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Biosense Webster
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Cosman Medical Inc.
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Diros Technology Inc.
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.5 NeuroTherm (St. Jude Medical).
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 St. Jude Medical.
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Stryker Corporation.
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 Kimberly-Clark.
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 RF Medical Co. Ltd.
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiative
5.10 AngioDynamics.
5.10.1 Company Overview
5.10.2 Financial Performance
5.10.3 Product Benchmarking
5.10.4 Strategic Initiatives
5.11 Covidien.
5.11.1 Company Overview
5.11.2 Financial Performance
5.11.3 Product Benchmarking
5.11.4 Strategic Initiatives
5.12 DFINE Inc.
5.12.1 Company Overview
5.12.2 Financial Performance
5.12.3 Product Benchmarking
5.12.4 Strategic Initiatives
5.13 STARmed.
5.13.1 Company Overview
5.13.2 Financial Performance
5.13.3 Product Benchmarking
5.13.4 Strategic Initiatives
5.14 Boston Scientific.
5.14.1 Company Overview
5.14.2 Financial Performance
5.14.3 Product Benchmarking
5.14.4 Strategic Initiatives

Chapter 6. Methodology and Scope
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources